Highlights

[PHARMA] QoQ Quarter Result on 2011-03-31 [#1]

Stock [PHARMA]: PHARMANIAGA BHD
Announcement Date 13-May-2011
Admission Sponsor -
Sponsor -
Financial Year 31-Dec-2011
Quarter 31-Mar-2011  [#1]
Profit Trend QoQ -     786.35%    YoY -     66.37%
Quarter Report


View:


Show?  QoQ % Horiz. %

Quarter Result
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Revenue 367,786 371,432 396,435 385,328 376,116 334,337 350,335 3.28%
  QoQ % -0.98% -6.31% 2.88% 2.45% 12.50% -4.57% -
  Horiz. % 104.98% 106.02% 113.16% 109.99% 107.36% 95.43% 100.00%
PBT 16,368 15,646 19,380 21,792 -2,701 15,405 20,327 -13.41%
  QoQ % 4.61% -19.27% -11.07% 906.81% -117.53% -24.21% -
  Horiz. % 80.52% 76.97% 95.34% 107.21% -13.29% 75.79% 100.00%
Tax -4,186 -4,687 -5,335 -6,193 749 -6,970 -5,809 -19.57%
  QoQ % 10.69% 12.15% 13.85% -926.84% 110.75% -19.99% -
  Horiz. % 72.06% 80.69% 91.84% 106.61% -12.89% 119.99% 100.00%
NP 12,182 10,959 14,045 15,599 -1,952 8,435 14,518 -11.01%
  QoQ % 11.16% -21.97% -9.96% 899.13% -123.14% -41.90% -
  Horiz. % 83.91% 75.49% 96.74% 107.45% -13.45% 58.10% 100.00%
NP to SH 11,942 10,811 13,920 15,484 -2,256 8,586 14,747 -13.09%
  QoQ % 10.46% -22.33% -10.10% 786.35% -126.28% -41.78% -
  Horiz. % 80.98% 73.31% 94.39% 105.00% -15.30% 58.22% 100.00%
Tax Rate 25.57 % 29.96 % 27.53 % 28.42 % - % 45.25 % 28.58 % -7.13%
  QoQ % -14.65% 8.83% -3.13% 0.00% 0.00% 58.33% -
  Horiz. % 89.47% 104.83% 96.33% 99.44% 0.00% 158.33% 100.00%
Total Cost 355,604 360,473 382,390 369,729 378,068 325,902 335,817 3.88%
  QoQ % -1.35% -5.73% 3.42% -2.21% 16.01% -2.95% -
  Horiz. % 105.89% 107.34% 113.87% 110.10% 112.58% 97.05% 100.00%
Net Worth 514,153 464,092 451,517 437,661 421,262 424,488 417,065 14.93%
  QoQ % 10.79% 2.79% 3.17% 3.89% -0.76% 1.78% -
  Horiz. % 123.28% 111.28% 108.26% 104.94% 101.01% 101.78% 100.00%
Dividend
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Div 35,296 - - - - - 50,261 -20.94%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 70.23% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
Div Payout % 295.57 % - % - % - % - % - % 340.83 % -9.04%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 86.72% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
Equity
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Net Worth 514,153 464,092 451,517 437,661 421,262 424,488 417,065 14.93%
  QoQ % 10.79% 2.79% 3.17% 3.89% -0.76% 1.78% -
  Horiz. % 123.28% 111.28% 108.26% 104.94% 101.01% 101.78% 100.00%
NOSH 117,655 106,933 106,994 107,007 106,919 106,924 106,939 6.55%
  QoQ % 10.03% -0.06% -0.01% 0.08% -0.00% -0.01% -
  Horiz. % 110.02% 99.99% 100.05% 100.06% 99.98% 99.99% 100.00%
Ratio Analysis
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
NP Margin 3.31 % 2.95 % 3.54 % 4.05 % -0.52 % 2.52 % 4.14 % -13.82%
  QoQ % 12.20% -16.67% -12.59% 878.85% -120.63% -39.13% -
  Horiz. % 79.95% 71.26% 85.51% 97.83% -12.56% 60.87% 100.00%
ROE 2.32 % 2.33 % 3.08 % 3.54 % -0.54 % 2.02 % 3.54 % -24.49%
  QoQ % -0.43% -24.35% -12.99% 755.56% -126.73% -42.94% -
  Horiz. % 65.54% 65.82% 87.01% 100.00% -15.25% 57.06% 100.00%
Per Share
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 312.60 347.35 370.52 360.09 351.78 312.69 327.60 -3.07%
  QoQ % -10.00% -6.25% 2.90% 2.36% 12.50% -4.55% -
  Horiz. % 95.42% 106.03% 113.10% 109.92% 107.38% 95.45% 100.00%
EPS 10.15 10.11 13.01 14.47 -2.11 8.03 13.79 -18.43%
  QoQ % 0.40% -22.29% -10.09% 785.78% -126.28% -41.77% -
  Horiz. % 73.60% 73.31% 94.34% 104.93% -15.30% 58.23% 100.00%
DPS 30.00 0.00 0.00 0.00 0.00 0.00 47.00 -25.81%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 63.83% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
NAPS 4.3700 4.3400 4.2200 4.0900 3.9400 3.9700 3.9000 7.86%
  QoQ % 0.69% 2.84% 3.18% 3.81% -0.76% 1.79% -
  Horiz. % 112.05% 111.28% 108.21% 104.87% 101.03% 101.79% 100.00%
Adjusted Per Share Value based on latest NOSH - 261,230
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
RPS 140.79 142.19 151.76 147.51 143.98 127.99 134.11 3.28%
  QoQ % -0.98% -6.31% 2.88% 2.45% 12.49% -4.56% -
  Horiz. % 104.98% 106.02% 113.16% 109.99% 107.36% 95.44% 100.00%
EPS 4.57 4.14 5.33 5.93 -0.86 3.29 5.65 -13.15%
  QoQ % 10.39% -22.33% -10.12% 789.53% -126.14% -41.77% -
  Horiz. % 80.88% 73.27% 94.34% 104.96% -15.22% 58.23% 100.00%
DPS 13.51 0.00 0.00 0.00 0.00 0.00 19.24 -20.95%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 70.22% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
NAPS 1.9682 1.7766 1.7284 1.6754 1.6126 1.6250 1.5965 14.93%
  QoQ % 10.78% 2.79% 3.16% 3.89% -0.76% 1.79% -
  Horiz. % 123.28% 111.28% 108.26% 104.94% 101.01% 101.79% 100.00%
Price Multiplier on Financial Quarter End Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 30/12/11 30/09/11 30/06/11 31/03/11 30/12/10 30/09/10 30/06/10 -
Price 5.3600 5.9000 5.9000 5.7300 5.3100 4.9800 4.9800 -
P/RPS 1.71 1.70 1.59 1.59 1.51 1.59 1.52 8.15%
  QoQ % 0.59% 6.92% 0.00% 5.30% -5.03% 4.61% -
  Horiz. % 112.50% 111.84% 104.61% 104.61% 99.34% 104.61% 100.00%
P/EPS 52.81 58.36 45.35 39.60 -251.66 62.02 36.11 28.75%
  QoQ % -9.51% 28.69% 14.52% 115.74% -505.77% 71.75% -
  Horiz. % 146.25% 161.62% 125.59% 109.66% -696.93% 171.75% 100.00%
EY 1.89 1.71 2.21 2.53 -0.40 1.61 2.77 -22.44%
  QoQ % 10.53% -22.62% -12.65% 732.50% -124.84% -41.88% -
  Horiz. % 68.23% 61.73% 79.78% 91.34% -14.44% 58.12% 100.00%
DY 5.60 0.00 0.00 0.00 0.00 0.00 9.44 -29.33%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 59.32% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
P/NAPS 1.23 1.36 1.40 1.40 1.35 1.25 1.28 -2.61%
  QoQ % -9.56% -2.86% 0.00% 3.70% 8.00% -2.34% -
  Horiz. % 96.09% 106.25% 109.38% 109.38% 105.47% 97.66% 100.00%
Price Multiplier on Announcement Date
31/12/11 30/09/11 30/06/11 31/03/11 31/12/10 30/09/10 30/06/10 CAGR
Date 22/02/12 01/11/11 10/08/11 13/05/11 25/02/11 04/11/10 11/08/10 -
Price 5.9000 5.9000 5.9000 5.0500 5.3500 4.9200 4.9500 -
P/RPS 1.89 1.70 1.59 1.40 1.52 1.57 1.51 16.09%
  QoQ % 11.18% 6.92% 13.57% -7.89% -3.18% 3.97% -
  Horiz. % 125.17% 112.58% 105.30% 92.72% 100.66% 103.97% 100.00%
P/EPS 58.13 58.36 45.35 34.90 -253.55 61.27 35.90 37.77%
  QoQ % -0.39% 28.69% 29.94% 113.76% -513.82% 70.67% -
  Horiz. % 161.92% 162.56% 126.32% 97.21% -706.27% 170.67% 100.00%
EY 1.72 1.71 2.21 2.87 -0.39 1.63 2.79 -27.50%
  QoQ % 0.58% -22.62% -23.00% 835.90% -123.93% -41.58% -
  Horiz. % 61.65% 61.29% 79.21% 102.87% -13.98% 58.42% 100.00%
DY 5.08 0.00 0.00 0.00 0.00 0.00 9.49 -34.00%
  QoQ % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -
  Horiz. % 53.53% 0.00% 0.00% 0.00% 0.00% 0.00% 100.00%
P/NAPS 1.35 1.36 1.40 1.23 1.36 1.24 1.27 4.14%
  QoQ % -0.74% -2.86% 13.82% -9.56% 9.68% -2.36% -
  Horiz. % 106.30% 107.09% 110.24% 96.85% 107.09% 97.64% 100.00%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.


NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ Δ & YoY Δ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.



  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
MQ Trader
Earn MQ Points while trading with MQ Traders Group
MQ Affiliate
Earn side income from MQ Affiliate Program
 
 

236  646  561  1008 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 AT 0.090.00 
 LCTITAN 2.14-0.26 
 SUPERMX-C1I 0.145-0.005 
 LUSTER 0.165-0.005 
 MAHSING 0.965-0.035 
 DGSB 0.225+0.01 
 HWGB 0.77+0.055 
 DATAPRP 0.19-0.03 
 MTOUCHE 0.05-0.005 
 KSTAR 0.43+0.06 

FEATURED POSTS

1. The Equity Market Index Benchmark in Malaysia CMS
2. Trading Scenarios of Derivatives Bursa Derivatives Education Series
3. Derivatives 101 Bursa Derivatives Education Series
4. Why Trade FKLI? Bursa Derivatives Education Series
5. MQ Trader - Introduction to MQ Trader Affiliate Program MQ Trader Announcement!

TOP ARTICLES

1. Supermax: my revised target price - Koon Yew Yin Koon Yew Yin's Blog
2. A LOOK AT CALVIN TAN RESEARCH STOCK PICKS (AS RECORDED BY PHILIP NOT PERFECTLY BUT CLEAR ENOUGH THE INVESTMENT APPROACH OF CALVIN TAN
3. Supermax: The Best Is Yet To Come- Myth or Truth Van Gogh of Financial
4. US has 2 Incurable Chronic Diseases - Koon Yew Yin Koon Yew Yin's Blog
5. [Humbled Investor] Supermx - Superb results - Estimation on Next QR Results HumbledInvestor
6. DOW CRASHED BY 650 POINTS ? NO FEAR AT ALL IF YOU KNOW THIS STOCK PROSPERED DURING ASIAN FINANCIAL CRISIS & SUBPRIME CRISIS OF 2007/8 COLLAPSE (WHAT? THE INVESTMENT APPROACH OF CALVIN TAN
7. LUXCHEM RESULT VERSUS HARTALEGA RESULT (COMPARE & CONTRAST) Calvin Tan Research THE INVESTMENT APPROACH OF CALVIN TAN
8. Traders Brief 27 Oct 2020 - Volatility Ahead Amid Internal and External Headwinds HLBank Research Highlights
PARTNERS & BROKERS